Phages plus antibiotics for heart infection treatment
Treatments studied
Part of Heart & circulation, Infections clinical trials.
This trial tests if adding bacteriophages (viruses that kill bacteria) to standard antibiotic treatment can help people with a serious heart valve infection called infective endocarditis. It may offer a new way to fight the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a current, active heart valve infection (infective endocarditis) diagnosed in or out of the hospital.
- Your infection meets the modified Duke 2023 criteria or is treated as endocarditis by your doctor.
- You are willing and able to give informed consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gathers information from patients with a heart infection called endocarditis to help doctors better understand and treat the condition. Anyone aged 16 or older with confirmed or suspected endocarditis who is being treated at Barts Heart Centre may be able to join.
This trial tests if the antibiotic dalbavancin can effectively treat a certain type of serious heart valve infection (endocarditis) caused by specific bacteria. You may be eligible if you have this infection in your left-sided heart valves and are at least 18 years old.
This study tests a new way to find the cause of infective endocarditis, a serious heart infection. It may help doctors choose the right treatment faster.
This trial compares taking antibiotics by mouth versus receiving antibiotics through a vein (outpatient IV) for an infection of the heart valve. It’s designed to see whether the oral option can work as well and safely, especially after initial treatment and surgery if needed.
This trial tests whether a treatment without rifampin works as well as one with rifampin for a type of heart valve infection caused by staph bacteria. It aims to find a simpler and safer option for patients with an infected artificial heart valve.
This trial measures how your body handles certain intravenous antibiotics used for endocarditis, an infection of the heart valves. It may help doctors understand the best antibiotic dosing for people with valve infections.
Hear when a new Endocarditis, Bacterial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.